Avoro Capital Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,111,111
| Closed | -$262M | – | 50 |
|
|
2023
Q4 | $262M | Buy |
11,111,111
+811,111
| +8% | +$14.4M | 3.63% | 13 |
|
|
2023
Q3 | $154M | Hold |
10,300,000
| – | – | 2.4% | 15 |
|
|
2023
Q2 | $113M | Hold |
10,300,000
| – | – | 1.53% | 16 |
|
|
2023
Q1 | $89.8M | Hold |
10,300,000
| – | – | 1.33% | 18 |
|
|
2022
Q4 | $64.6M | Hold |
10,300,000
| – | – | 0.97% | 20 |
|
|
2022
Q3 | $36M | Hold |
10,300,000
| – | – | 0.67% | 25 |
|
|
2022
Q2 | $30.4M | Hold |
10,300,000
| – | – | 0.6% | 27 |
|
|
2022
Q1 | $32M | Hold |
10,300,000
| – | – | 0.58% | 26 |
|
|
2021
Q4 | $34.8M | Hold |
10,300,000
| – | – | 0.59% | 28 |
|
|
2021
Q3 | $37.6M | Hold |
10,300,000
| – | – | 0.59% | 25 |
|
|
2021
Q2 | $44.9M | Hold |
10,300,000
| – | – | 0.78% | 27 |
|
|
2021
Q1 | $46.8M | Hold |
10,300,000
| – | – | 0.81% | 26 |
|
|
2020
Q4 | $59.1M | Hold |
10,300,000
| – | – | 1.02% | 22 |
|
|
2020
Q3 | $74.6M | Buy |
10,300,000
+5,050,000
| +96% | +$27M | 1.06% | 22 |
|
|
2020
Q2 | $18.3M | Sell |
5,250,000
-250,000
| -5% | -$721K | 0.36% | 34 |
|
|
2020
Q1 | $8.14M | Hold |
5,500,000
| – | – | 0.28% | 34 |
|
|
2019
Q4 | $10.8M | Buy |
5,500,000
+2,800,000
| +104% | +$10.5M | 0.32% | 27 |
|
|
2019
Q3 | $13.8M | Hold |
2,700,000
| – | – | 0.58% | 27 |
|
|
2019
Q2 | $19.3M | Buy |
2,700,000
+1,975,000
| +272% | +$22.4M | 0.67% | 25 |
|
|
2019
Q1 | $9.63M | Buy |
+725,000
| New | +$7.71M | 0.42% | 26 |
|
|
2018
Q3 | – | Sell |
-1,282,374
| Closed | -$17.2M | – | 51 |
|
|
2018
Q2 | $17.2M | Buy |
+1,282,374
| New | +$16M | 0.66% | 27 |
|